Metoprolol Medical Valley (Metoprolol Tartrate)

Metoprolol works by selectively blocking β1‑adrenergic receptors in the heart. This inhibition reduces the effects of adrenaline and noradrenaline, leading to a slower heart rate, decreased contractility, and lower cardiac output, which together lower blood pressure and lessen the heart’s oxygen demand.

The appropriate dose of Metoprolol Medical Valley is determined by the prescribing healthcare professional based on the patient’s specific condition, response to therapy, and any co‑existing medical issues. Dosage adjustments are made individually and should follow the prescriber’s instructions.

The safety of metoprolol during pregnancy or lactation has not been definitively established. Healthcare providers weigh potential benefits against possible risks before prescribing it to pregnant or nursing women, and alternative therapies may be considered when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol is a cardio‑selective (β1‑selective) beta‑blocker, which generally results in fewer respiratory side effects compared with non‑selective agents like propranolol. Its pharmacokinetic profile allows once‑ or twice‑daily dosing, and it is widely used for both hypertension and heart‑failure management.

Metoprolol Medical Valley should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Metoprolol Medical Valley is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their clinician.

The most serious risks include severe bradycardia, heart block, marked hypotension, and bronchospasm, particularly in patients with underlying respiratory disease. Prompt medical attention is required if symptoms such as fainting, chest pain, severe shortness of breath, or sudden weakness occur.

Metoprolol should be avoided in individuals with known hypersensitivity to metoprolol or any component of the formulation, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, and patients with uncompensated heart failure or severe peripheral vascular disease unless specifically directed by a physician.